Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive entities : Biontech se save search
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
Published: 2023-10-26 (Crawled : 11:00) - globenewswire.com
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: -0.39%
H: 2.48%
C: 1.8%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.99%
H: 1.81%
C: 0.47%
covid-19 vaccine positive influenza topline program
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
Published: 2023-10-23 (Crawled : 15:30) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -0.48%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -2.24%
H: 7.12%
C: 4.11%
bnt211 candidate congress tumors positive update cell car-t therapy
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
Published: 2023-08-30 (Crawled : 14:00) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
covid-19 chmp vaccine positive
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
Published: 2023-06-02 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 3.21%
H: 2.0%
C: 0.62%
bnt316 candidate antibody asco positive
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union
Published: 2022-11-10 (Crawled : 15:00) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -3.15%
H: 4.22%
C: 4.22%
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: 1.72%
H: 0.47%
C: -0.31%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -4.59%
H: 3.28%
C: 3.06%
covid-19 chmp children vaccine positive
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 6 Months to less than 5 Years in the European Union
Published: 2022-10-19 (Crawled : 16:00) - globenewswire.com
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: -0.41%
H: 0.36%
C: -1.82%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -1.37%
H: 0.37%
C: -6.97%
comirnaty comirnaty® chmp children positive
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
Published: 2022-10-13 (Crawled : 11:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -4.1%
H: 0.0%
C: 0.0%
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -1.78%
H: 0.0%
C: 0.0%
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: -0.64%
H: 3.35%
C: 2.92%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -2.2%
H: 6.32%
C: 4.76%
trial positive
Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union
Published: 2022-09-16 (Crawled : 12:20) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 0.74%
H: 0.91%
C: -0.74%
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: 0.33%
H: 1.15%
C: -0.13%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.52%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -1.82%
H: 3.27%
C: 3.0%
comirnaty comirnaty® chmp authorization positive
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
Published: 2022-09-01 (Crawled : 14:00) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -4.51%
H: 1.07%
C: 1.07%
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: -0.2%
H: 3.35%
C: 3.3%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -3.04%
H: 0.45%
C: 0.05%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 0.68%
H: 1.61%
C: 1.5%
covid-19 chmp vaccine positive
Positive Phase 1 Data from mRNA-based Individualized Neoantigen Specific Immunotherapy in Patients with Resected Pancreatic Cancer presented at ASCO
Published: 2022-06-05 (Crawled : 20:20) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
| Email alert
Add to watchlist
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
| Email alert
Add to watchlist
immunotherapy asco positive cancer pancreatic phase 1
Pfizer, BioNTech Seek Approval for Boosters in Children Following Positive Data
Published: 2022-04-14 (Crawled : 15:20) - biospace.com/
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -0.67%
H: 1.98%
C: -1.62%
children approval positive
BioNTech Presents Positive Preliminary Phase 1/2 Data for First-in-Class CAR-T Program BNT211 at AACR
Published: 2022-04-11 (Crawled : 08:00) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 3.07%
H: 0.0%
C: -0.32%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 4.5%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -2.44%
H: 3.61%
C: 2.68%
bnt211 car-t program positive phase 1
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union
Published: 2021-11-25 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
| Email alert
Add to watchlist
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
| Email alert
Add to watchlist
comirnaty comirnaty® europe positive chmp children
Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union
Published: 2021-10-04 (Crawled : 17:00) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -7.79%
H: 7.42%
C: 5.95%
covid europe positive vaccine chmp covid-19
Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
Published: 2021-09-20 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.35%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -8.02%
H: 3.64%
C: -0.64%
covid positive results topline children vaccine trial
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
Published: 2021-03-31 (Crawled : 11:00) - globenewswire.com
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: 0.11%
H: 0.77%
C: 0.22%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.59%
H: 0.36%
C: 0.12%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 4.81%
H: 1.4%
C: -0.25%
covid positive results topline vaccine covid-19
Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine
Published: 2020-12-21 (Crawled : 15:00) - biospace.com/
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: -1.06%
H: 0.32%
C: 0.27%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 3.14%
H: 0.43%
C: -0.98%
covid vaccine positive chmp covid-19
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.